Elder Projects Peer Comparison

BSE: 524788

₹20.15

₹0.00 (0.00%)

As on 03-Dec-2015IST

Market cap

₹7 Cr

Revenue (TTM)

₹2 Cr

P/E Ratio

--

P/B Ratio

-1.4

Div. Yield

0 %

Edit

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Market cap (₹ Cr)	7	32,104	29,892	29,103	26,871
Revenue (₹ Cr)	2	3,564	1,936	9,205	1,462
Net Profit (₹ Cr)	-2.98	414.00	288.22	-371.81	387.35
Net Margin (%)	-73.29	11.23	14.79	-3.93	26.01
RoE (%)	--	8.38	29.77	-3.85	25.18
Price to Earnings	--	78.49	103.71	--	69.57
Price-To-Book	-1.44	6.38	22.27	3.64	15.55

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Operating Revenue	9.77	4,350.50	34.80	--	33.90
Total Income	11.11	4,375.84	34.80	--	34.61
Total Expenditure	7.38	2,996.79	25.65	--	30.42
EBITDA	2.39	1,353.71	9.15	--	3.48
Depreciation	0.60	115.07	2.71	--	1.05
EBIT	1.79	1,238.64	6.44	--	2.42
Interest	2.83	269.02	2.51	--	1.10
Other Income	1.34	25.34	0.42	--	0.71
Exceptional Items	--	-473.77	--	--	--
Profit before Tax	0.30	521.19	3.93	--	2.03
Provision for Tax	0.24	221.74	1.40	--	0.68
Profit after Tax	0.06	299.45	2.52	--	1.35

Liabilities (₹ Cr)

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Shareholder's Funds	1.96	1,471.02	37.49	--	6.11
Minority Interest	--	--	--	--	--
Non-Current Liabilities	-0.74	2,891.88	5.39	--	0.04
Current Liabilities	22.51	1,890.94	24.92	--	15.82
Total Liabilities	24.72	6,253.84	67.79	--	22.09

Assets (₹ Cr)

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Non-Current Assets	19.40	3,772.33	47.64	--	5.51
Current Assets	4.28	2,481.51	20.15	--	16.45
Total Assets	24.72	6,253.84	67.79	--	22.09
Total Debt*	20.96	3,492.50	19.14	--	6.41
Net Current Assets	-18.23	590.57	-4.76	--	0.63
Contingent Liabilities	0.10	46.91	0.71	--	--

Cashflow (₹ Cr)

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Cash From Operating Activities	2.95	1,343.83	5.07	--	--
Cash Flow from Investing Activities	-1.08	-305.45	-4.60	--	--
Cash from Financing Activities	-1.75	-826.56	-0.83	--	--
Net Cash Inflow / Outflow	0.12	211.82	-0.36	--	0.00

Ratios

Profitability Ratios

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
ROCE (%)	14.41	16.20	12.09	--	25.61
ROE (%)	2.97	66.74	14.65	--	24.87
ROA (%)	0.25	4.97	4.06	--	6.42
EBIT Margin (%)	38.18	31.70	26.29	--	12.34
Net Margin (%)	0.50	6.84	7.25	--	3.90
Cash Profit Margin (%)	6.74	9.52	15.04	--	6.56

Growth Ratios

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Revenue Growth (%)	11.63	15.97	65.29	--	21.86
EBIT Growth (%)	29.33	29.05	42.04	--	27.63
Net Profit Growth (%)	428.99	212.90	6.25	--	7.55
EPS Growth (%)	428.82	278.36	6.25	--	7.55
Book Value Growth (%)	4.43	253.45	15.81	--	28.51

Valuation Ratios

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Price / Earnings	0.00	17.64	0.00	--	0.00
Price / Book Value	0.00	9.37	0.00	--	0.00
Dividend Yield (%)	--	0.00	--	--	--
EV/EBITDA	6.40	7.33	4.36	--	1.71
Market Cap (₹ Cr)	0.00	6,555.46	0.00	--	0.00

Solvency Ratios

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debt to Equity	10.96	2.39	0.51	--	1.05
Short term debt to equity ratio	10.59	0.18	0.21	--	0.88
Current Ratio	0.19	1.31	0.81	--	1.04
Quick Ratio	0.17	0.84	0.77	--	0.66
Interest Coverage	1.11	2.94	2.57	--	2.86

Operating Efficiency Ratios

	Elder Projects	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debtors to sales (%)	23.49	17.44	42.51	--	24.27
Asset Turnover	0.44	0.72	0.56	--	1.74
Receivable days	57.99	57.17	120.33	--	81.45
Inventory Days	19.63	67.16	9.04	--	45.36
Payable days	330.95	116.25	535.25	--	134.63
Cash Conversion Cycle	-253.33	8.07	-393.94	--	-7.82

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly